Secondly, the “Incidence - SEER Research Data, 8 Registries, Nov 2023 Sub (1975–2021)” package lacks data on molecular biomarkers such as microsatellite instability/mismatch repair and RAS/BRAF mutations, which are considered valuable in colorectal cancer prognosis. This evidence concerns the gene BRAF and colorectal cancer.